-+ 0.00%
-+ 0.00%
-+ 0.00%

Resverlogix Q2 2026 loss widens as finance costs climb, including royalty preferred share revaluation

PUBT·08/14/2026 15:40:22
Listen to the news
Resverlogix Q2 2026 loss widens as finance costs climb, including royalty preferred share revaluation
  • For the three months ended June 30, 2026, net loss widened to USD 6.08 million from USD 1.61 million, driven by higher finance costs.
  • Finance costs rose to USD 4.61 million from USD 0.33 million, reflecting royalty preferred shares fair-value losses, interest, accretion, and a debt modification loss.
  • Operating expenses increased to USD 1.47 million from USD 1.27 million, led by higher R&D tied to the post-COVID-19 conditions study.
  • Liquidity remained strained with USD 0.1 million cash against USD 19.5 million payables, including USD 13.7 million owed to EVERSANA.
  • Zenith advances provided USD 2.2 million in the first six months, while USD 12.1 million of promissory notes to Zenith remained outstanding.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Resverlogix Corporation published the original content used to generate this news brief on August 14, 2026, and is solely responsible for the information contained therein.